What's breaking now, across thousands of outlets.
Key PointsAlibaba looks cheap, but its earnings are falling sharply while AI and instant-commerce spending drain cash.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The partnership will bring Noom Weight, Diabetes Prevention Program and a no-cost GLP-1 companion to Solera Health members
Novartis’ BTK inhibitor Rhapsido has a chance of expanding from a chronic itch treatment to the multiple sclerosis market following wins in two identical Phase 3 trials.
Sharjah: Doctors at Kuwait Hospital in Sharjah saved the life of a patient who swallowed a 12-centimetre nail and a metal spoon, causing serious damage to the intestine, authorities said on Tuesday.
Scott McTominay will undergo corrective heart surgery after Napoli confirmed the midfielder has been diagnosed with a mild, benign cardiac arrhythmia.The Serie A giants announced on Tuesday that the…
An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found…
